Cash burn is still massive compared to revenues, and even after the R&D rebate is accounted for, still less than nine months of runway.
The company needs to elaborate in more detail on their business plan to achieve positive cash flow. This quarterly report is a random hodge-podge of product development, research, new markets, and regulatory approvals. None of this has any value unless it translates to improved cash flow. The business has enough history now to develop (and publish) a business plan to give us some more confidence that they can make it through to self-sustaining activity.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $66.31M | |||
| Open | High | Low | Value | Volume |
| 3.5¢ | 3.6¢ | 3.5¢ | $41.13K | 1.150M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1241361 | 3.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 103780 | 3 |
View Market Depth
| Last trade - 15.18pm 18/06/2025 (20 minute delay) ? |
| PCK (ASX) Chart |